C12Y 301/03031
Nucleotidase
Official title: Nucleotidase (3.1.3.31)
C12Y301/03031 (Nucleotidase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Selection and Use of Melatonin Supporting Bacteria to Reduce Infantile Colic4 Jul 2024US 2024/0216447 A1Biogaia AB
- Binding proteins comprising the extracellular domain of cd39 and methods of treating or preventing neurological diseases14 Dec 2023US 2023/0399376 A1Baker Heart and Diabetes Institute
- Selection and Use of Melatonin Supporting Bacteria to Reduce Infantile Colic3 Nov 2022US 2022/0347237 A1Biogaia AB
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.